Pay in 4 interest-free payments of $29.75 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Diphenylterazine injections into untransfected BALB/c mice do not yield any background emission
Smiles: CC(C)(C)NC(=O)N1CCN(CC1)C(=O)N1[C@@H]([C@@H](CCCN=C(N)N)C1=O)C(O)=O
Formula: C24H31N3O3
Formula: C19H19ClN6O4S3
COCCOCCOCCN(CC(C)(C)S)C1=CC(COC2=CC3N[C@H]([C@@H]4CC5=CC=CC=C5N4C(=O)C=3C=C2OC)S([O-])(=O)=O)=CC(COC2=CC3NC[C@@H]4CC5=CC=CC=C5N4C(=O)C=3C=C2OC)=C1
Z-VDVAD-FMK 21843 Diphenylterazine injections into untransfected BALB/cJurkat T lymphocytes treated with an irreversible caspase 2 inhibitor, benzyloxycarbonyl Val Asp(OMe) Val Ala Asp(OMe) fluoromethyl ketone (Z VDVAD FMK), or stably transfected with pro caspase 2 antisense (Casp 2 AS) are refractory to cytochrome c release stimulated by etoposide1. When etoposide induced activation of pro caspase 2 is subverted by Z VDVAD FMK or stable transfection of pro caspase 2 antisense, cytochrome c release and other
US$ 193.00
US$ 205.00
US$ 268.50
US$ 205.00
US$ 4072.00
US$ 924.50
US$ 268.50
US$ 217.00
US$ 610.50
US$ 1404.50
US$ 248.00
US$ 618.00